Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Escherichia coli-derived recombinant human bone morphogenetic protein-2 combined with bone marrow-derived mesenchymal stromal cells improves bone regeneration in canine segmental ulnar defects

Fig. 2

Radiographs of the postoperative changes. a–x Postoperative images taken at 4, 8 and 12 weeks after surgery are shown for all six experimental groups: 560 μg rhBMP-2 with 107 (a–d), 105 (e–h), and 0 (i–l) cells, and 140 μg rhBMP-2 with 107 (m–p), 105 (q–t), and 0 (u–x) cells. The groups transplanted with BMSCs form more regenerated bone than the groups without cells at the same dose of rhBMP-2

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us